Medtronic plc. Ordinary Shares (MDT): Price and Financial Metrics
Medtronic plc. Ordinary Shares (MDT)
Today's Latest Price: $103.06 USD
Updated Sep 30 3:22pm
Add MDT to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 140 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
MDT Stock Summary
- MDT has a higher market value than 98.77% of US stocks; more precisely, its current market capitalization is $138,037,465,152.
- Medtronic plc's stock had its IPO on January 1, 1986, making it an older stock than 92.91% of US equities in our set.
- In terms of volatility of its share price, MDT is more volatile than only 8.95% of stocks we're observing.
- If you're looking for stocks that are quantitatively similar to Medtronic plc, a group of peers worth examining would be DHR, TMUS, SNY, UNP, and CHTR.
- MDT's SEC filings can be seen here. And to visit Medtronic plc's official web site, go to www.medtronic.com.
MDT Stock Price Chart Technical Analysis Charts
MDT Price/Volume Stats
| Current price | $103.06 | 52-week high | $122.15 |
| Prev. close | $102.69 | 52-week low | $72.13 |
| Day low | $102.50 | Volume | 3,647,131 |
| Day high | $104.87 | Avg. volume | 5,921,638 |
| 50-day MA | $102.26 | Dividend yield | 2.26% |
| 200-day MA | $101.57 | Market Cap | 138.53B |
Medtronic plc. Ordinary Shares (MDT) Company Bio
Medtronic plc manufactures and sells device-based medical therapies worldwide. The company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The company was founded in 1949 and is based in Dublin, Ireland.
MDT Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $103.06 | $37.8 | -63% |
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Medtronic plc. To summarize, we found that Medtronic plc ranked in the 23th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. In terms of the factors that were most noteworthy in this DCF analysis for MDT, they are:
- Medtronic plc's weighted average cost of capital (WACC) is 8%; for context, that number is higher than just 24.65% of tickers in our DCF set.
- MDT's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than just 24.65% of tickers in our DCF set.
- As a business, Medtronic plc experienced a tax rate of about 0% over the past twelve months; relative to its sector (Healthcare), this tax rate is higher than merely 0% of stocks generating free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -64% |
| 1% | -64% |
| 2% | -63% |
| 3% | -63% |
| 4% | -62% |
| 5% | -62% |
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as MDT, try SNN, BAX, GMED, HOLX, and OFIX.
Loading social stream, please wait...